Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-041818
Filing Date
2022-04-01
Accepted
2022-04-01 17:01:07
Documents
12
Period of Report
2021-12-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2211325d1_8ka.htm   iXBRL 8-K/A 24277
  Complete submission text file 0001104659-22-041818.txt   202822

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20211222.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20211222_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20211222_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2211325d1_8ka_htm.xml XML 4635
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39752 | Film No.: 22799191
SIC: 2834 Pharmaceutical Preparations